In this study, we demonstrated that the ectonucleotidase CD73, often overexpressed on tumor cells and considered as an important cancer immune checkpoint, enhances tumor cell metabolic fitness in a cell-autonomous manner. The gene discussed is NT5E; the disease is cancer.